Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.33
+0.05 (0.80%)
Feb 6, 2026, 11:58 AM EST - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $164.6 million as of February 6, 2026. Its market cap has decreased by -66.43% in one year.
Market Cap
164.60M
Enterprise Value
32.52M
1-Year Change
-66.43%
Ranking
Category
Stock Price
$6.33
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has decreased from $166.07M to $164.60M, a decrease of -0.88%. That is a compound annual growth rate of -0.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 163.30M | -12.90% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 171.40M |
| Humacyte | 171.03M |
| Prelude Therapeutics | 166.44M |
| C4 Therapeutics | 165.72M |
| Innate Pharma | 164.84M |
| Editas Medicine | 162.54M |
| Tenaya Therapeutics | 162.38M |
| Tiziana Life Sciences | 162.08M |